A Study of CC-99677 in Participants With Active Ankylosing Spondylitis
Public ClinicalTrials.gov record NCT04947579. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of CC-99677 in Subjects With Active Ankylosing Spondylitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to learn about response to CC-99677 treatment by measuring signs and symptoms of Ankylosing Spondylitis (AS), objective measures of disease activity, quality of life assessments, pharmacokinetics, safety, and tolerability over a 12-week double-blind period.
Study identification
- NCT ID
- NCT04947579
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 167 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 25, 2021 (Actual)
- Primary completion
- Feb 21, 2023 (Actual)
- Completion
- Feb 21, 2023 (Actual)
- Last update posted
- May 1, 2024
2021 – 2023
United States locations
- U.S. sites
- 16
- U.S. states
- 8
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 024 | Flagstaff | Arizona | 86001 | — |
| Local Institution - 021 | Gilbert | Arizona | 58297 | — |
| Local Institution - 022 | Phoenix | Arizona | 95037 | — |
| Local Institution - 025 | Tucson | Arizona | 85704 | — |
| Local Institution - 017 | Tustin | California | 92780 | — |
| Local Institution - 026 | Saint Clair Shores | Michigan | 48081 | — |
| Local Institution - 028 | Cleveland | Ohio | 44106 | — |
| Local Institution - 004 | Dayton | Ohio | 45417 | — |
| Local Institution - 009 | Portland | Oregon | 97239 | — |
| Local Institution - 003 | Duncansville | Pennsylvania | 16635 | — |
| Local Institution - 005 | Jackson | Tennessee | 38305 | — |
| Local Institution - 002 | Memphis | Tennessee | 38119 | — |
| Local Institution - 029 | Austin | Texas | 78731 | — |
| Local Institution - 006 | Colleyville | Texas | 76034 | — |
| Local Institution - 019 | Fort Worth | Texas | 76107 | — |
| Local Institution - 008 | Houston | Texas | 77099 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04947579, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 1, 2024 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04947579 live on ClinicalTrials.gov.